跳至主要内容
临床试验/NCT02589002
NCT02589002已完成不适用

Effects of Sucralose on Insulin Sensitivity, Pancreatic Response and Appetite Regulating Hormones

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran1 个研究点 分布在 1 个国家目标入组 66 人开始时间: 2015年7月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
66
试验地点
1
主要终点
Insulin sensitivity

研究概览

简要总结

In this study the effects of sucralose on insulin sensitivity, beta-cell response and appetite regulating hormones will be evaluated.

详细描述

The consumption of non-nutritive sweeteners has a high prevalence. The effect of non-nutritive sweeteners in both beta-cell function and insulin resistance it is unknown.

Previous studies performed in animal models and humans with diverse characteristics have shown variable effects of different non-nutritive sweeteners in variables related to glucose metabolism.

Due to the high consumption of non-nutritive sweeteners it is relevant to know its effect in beta cell-function and insulin sensitivity.

In this study the effects of sucralose, a non-nutritive sweetener that is highly consumed in the population, on insulin sensitivity and beta-cell function will be evaluated.

54 participants with normal glucose tolerance, normal weight, and without chronic diseases with a low consumption of non-nutritive sweeteners will be included. The participants will be randomly assigned to consume sucralose or to a control group.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • both genders
  • age between 18 and 55 years
  • body mass index ≥18.5 and <25 kg/m2
  • low consumption of non-nutritive sweeteners

排除标准

  • diabetes or glucose intolerance
  • consumption of medications affecting insulin sensitivity (metformin, steroids, hormone replacement therapy, contraceptives)
  • intestinal disease such as malabsorption or previous intestinal resection
  • history of bariatric surgery
  • pregnancy or lactation
  • weight loss greater than 5% in the previous month

研究组 & 干预措施

Control

No Intervention

Absence of sucralose ingestion

Sucralose

Experimental

Ingestion of 15% of the ADI of sucralose daily during two weeks

干预措施: Sucralose (Other)

结局指标

主要结局

Insulin sensitivity

时间窗: Two weeks

Insulin sensitivity and pancreatic response estimated with the minimal model using a frequently sampled IV glucose tolerance test

次要结局

  • Leptin change(Two weeks)
  • Glucagon like peptide (GLP-1) change(Two weeks)
  • Ghrelin change(Two weeks)
  • Tyrosine-tyrosine peptide (PYY) change(Two weeks)

研究者

发起方
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验